A Comparison of the Safety and Comfort of AC-170

Phase 1CompletedNCT01495338

Aciex Therapeutics, Inc.60 enrolled

Overview

The purpose of this study is to evaluate the safety and comfort of AC-170 compared to a placebo.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Normal Ocular Health

Interventions

AC-170 0.17%DRUG

1 drop in one eye at one timepoint

AC-170 0.24% (Formulation 1)DRUG

1 drop in one eye at one timepoint

AC-170 0.24% (Formulation 2)DRUG

1 drop in one eye at one timepoint

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Able and willing to avoid the use of ocular medications or topical ocular preparations within protocol specific time period. Exclusion Criteria: * Known contraindications or sensitivities to the study medication or its components. * Any ocular condition that, in the opinion of the investigator, could affect the subjects safety or trial parameters. * Use of disallowed medications during the period indicated prior to the study enrollment or during the study.

Locations (1)

Andover Eye Associates

Andover, Massachusetts, United States

Outcomes

Primary Outcomes

Drop Comfort Score

drop comfort on 0-10 scale

Time frame: during 3 minute period

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.